Этарацизумаб

Rec. INN (наименование, зарегистрированное ВОЗ)

DB12213

892553-42-3

immunoglobulin G1, anti-[Homo sapiens alphaVbeta3 integrin (CD51/CD61, CD51/GPIIIa, CD51/platelet membrane glycoprotein IIIa, vitronectin receptor)], humanized monoclonal antibody, MEDI522 (or hLM609); gamma1 heavy chain (1-447) [humanized VH (Homo sapiens FR/Mus musculus CDR from clone LM609-Homo sapiens IGHJ5*01, L123>T) [8.8.10] (1-117) -Homo sapiens IGHG1*03 (118-447)], (220-214’)-disulfide with kappa light chain (1'- 214') [humanized V-KAPPA (Homo sapiens FR/Mus musculus CDR from clone LM609-Homo sapiens IGKJ4*01) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')]; (226-226”:230-230”)-bisdisulfide dimer

C₆₃₉₂H₉₉₀₈N₁₇₃₂O₁₉₉₆S₄₂

144302,22 г/моль

Поделиться этой страницей